Digital health company etectRx has entered into an agreement with Pear Therapeutics, Inc. to develop up to two product candidates in the Central Nervous...
Proteus has prematurely ended its high profile $88 million deal with Otsuka, reports MobiHealthNews. Proteus’ CEO, Andrew Thompson, told STAT News that the company...